Personal information

Emails & domains

Verified email domains

Websites & social links

Academic Website

Other IDs

ResearcherID: I-7956-2013
Scopus Author ID: 6603440272

Keywords

Medicinal Chemistry, Physical Biochemistry, CADD, PDT, cationic porphyrin, chlorophyll derivatives

Activities

Collapse all

Employment (1)

School of Pharmacy, Bandung Institute of Technology: Bandung, West Java, ID

1992-03-01 to present | Professor in Medicinal Chemistry (Pharmacochemistry)
Employment
Source: Self-asserted source
Daryono Hadi Tjahjono

Education and qualifications (4)

Keio Gijuku Daigaku - Yagami Campus: Yokohama, Kanagawa, JP

1998-04-01 to 2000-12-20 | Ph.D (Applied Chemistry)
Education
Source: Self-asserted source
Daryono Hadi Tjahjono

Keio Gijuku Daigaku - Yagami Campus: Yokohama, Kanagawa, JP

1996-04-01 to 1998-03-23 | M.Sc. (Applied Chemistry)
Education
Source: Self-asserted source
Daryono Hadi Tjahjono

Institut Teknologi Bandung: Bandung, Jawa Barat, ID

1990-04-01 to 1991-05-17 | Pharmacist (Pharmacy)
Education
Source: Self-asserted source
Daryono Hadi Tjahjono

Institut Teknologi Bandung: Bandung, Jawa Barat, ID

1985-08-18 to 1990-03-03 | B.Sc. (Pharmacy)
Education
Source: Self-asserted source
Daryono Hadi Tjahjono

Professional activities (2)

Society of Porphyrins and Phthalocyanines : Dijon, FR

2004-04-08 to present | Country representative
Service
Source: Self-asserted source
Daryono Hadi Tjahjono

American Chemical Society: Washington D.C., District of Columbia, US

1997-05-15 to present (Medicinal Chemistry)
Membership
Source: Self-asserted source
Daryono Hadi Tjahjono

Funding (4)

Kajian Molekul Antivirus Sars-Cov-2 Secara In Silico (In silico study for repurposing the existing molecules/medicines as anti-SARS-CoV-2)

2020-07 to 2021-06 | Grant
Ministry of Research and Technology (Jakarta, Jakarta, ID)
GRANT_NUMBER:

104/F1/PKS-KCOVID-19.F/VI/2020
Source: Self-asserted source
Daryono Hadi Tjahjono

Senyawa Turunan Porfirin sebagai Kit Radiofarmaka untuk Diagnostik dan Terapi Kanker (Porphyrin derivatives as ligand of radiopharmaceutical for diagnosing and therapy of cancer

2019-01 to 2021-12 | Grant
Ministry of Research and Technology (Jakarta, Jakarta, ID)
GRANT_NUMBER:

NK: 2/E1/KP.PTNBH/201
Source: Self-asserted source
Daryono Hadi Tjahjono

Hitachi Fellow

2008-06 to 2008-09 | Award
Hitachi Scholarship Foundation (Tokyo, JP)
Source: Self-asserted source
Daryono Hadi Tjahjono

Hitachi Fellow

2003-07 to 2003-10 | Award
Hitachi Scholarship Foundation (Tokyo, JP)
Source: Self-asserted source
Daryono Hadi Tjahjono

Peer review (32 reviews for 17 publications/grants)

Review activity for ACS central science. (1)
Review activity for Arabian journal of chemistry. (1)
Review activity for Computational biology and chemistry. (1)
Review activity for F1000Research. (1)
Review activity for Heliyon. (2)
Review activity for IEEE/ACM transactions on computational biology and bioinformatics. (1)
Review activity for International journal of peptide research and therapeutics. (2)
Review activity for Journal of biomolecular structure and dynamics. (11)
Review activity for Journal of mathematical and fundamental Sciences. (2)
Review activity for Medicinal chemistry research. (1)
Review activity for Medicinal chemistry research. (1)
Review activity for Molecules. (1)
Review activity for New journal of chemistry. (1)
Review activity for PloS one. (1)
Review activity for Polymers for advanced technologies. (1)
Review activity for RSC advances (3)
Review activity for The journal of physical chemistry. (1)
How many people are using ORCID?